stella
beta
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer — Stella
Recruiting
Back to Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Liaoning Cancer Hospital and Institute, Shenyang, Liaoning
View full record on ClinicalTrials.gov